Disclosed herein are methods for the reduction of inter-patient variability of a drug, such as in one or more parameters including half-lite (t ½ ), maximum plasma concentration (C max ), time at maximal plasma concentration (T max ), area under the time-versus-concentration curve (AUC). Also provided are methods of reducing side effects associated with drugs.
